- Home
- ONCY vs PROP Comparison
ONCY vs PROP Comparison
Compare ONCY & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- PROP
- Stock Information
- Founded
- ONCY 1998
- PROP 2001
- Country
- ONCY Canada
- PROP United States
- Employees
- ONCY N/A
- PROP N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- PROP Investment Bankers/Brokers/Service
- Sector
- ONCY Health Care
- PROP Finance
- Exchange
- ONCY Nasdaq
- PROP Nasdaq
- Market Cap
- ONCY 89.7M
- PROP 99.8M
- IPO Year
- ONCY 1999
- PROP N/A
- Fundamental
- Price
- ONCY $1.11
- PROP $1.91
- Analyst Decision
- ONCY Strong Buy
- PROP Buy
- Analyst Count
- ONCY 5
- PROP 5
- Target Price
- ONCY $5.00
- PROP $6.75
- AVG Volume (30 Days)
- ONCY 900.3K
- PROP 1.9M
- Earning Date
- ONCY 11-07-2025
- PROP 11-14-2025
- Dividend Yield
- ONCY N/A
- PROP N/A
- EPS Growth
- ONCY N/A
- PROP N/A
- EPS
- ONCY N/A
- PROP N/A
- Revenue
- ONCY N/A
- PROP $88,854,000.00
- Revenue This Year
- ONCY N/A
- PROP $4,508.14
- Revenue Next Year
- ONCY N/A
- PROP $61.49
- P/E Ratio
- ONCY N/A
- PROP N/A
- Revenue Growth
- ONCY N/A
- PROP N/A
- 52 Week Low
- ONCY $0.33
- PROP $1.64
- 52 Week High
- ONCY $1.51
- PROP $10.58
- Technical
- Relative Strength Index (RSI)
- ONCY 39.70
- PROP 46.79
- Support Level
- ONCY $1.16
- PROP $1.92
- Resistance Level
- ONCY $1.32
- PROP $2.10
- Average True Range (ATR)
- ONCY 0.07
- PROP 0.15
- MACD
- ONCY -0.01
- PROP 0.03
- Stochastic Oscillator
- ONCY 10.42
- PROP 44.25
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.